+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Testosterone Replacement Therapy Market by Treatment Method, Application, End User - Global Forecast to 2030

  • PDF Icon

    Report

  • 198 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5666355
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The testosterone replacement therapy (TRT) market is evolving rapidly, propelled by clinical innovation, changing patient profiles, and the integration of digital health technologies. Industry stakeholders face a landscape shaped by fresh regulatory challenges and shifting consumer expectations, necessitating emerging strategies focused on patient-centricity, operational resilience, and value-based care.

Market Snapshot: Testosterone Replacement Therapy Market Overview

The Testosterone Replacement Therapy Market grew from USD 850.48 million in 2024 to USD 898.36 million in 2025. It is expected to continue growing at a CAGR of 5.76%, reaching USD 1.19 billion by 2030.

Scope & Segmentation Analysis

  • Treatment Methods: Implants and pellets, injectable formulations (intramuscular, subcutaneous), intranasal medications, oral medications, patches (cheek/buccal, transdermal), and topical gels.
  • Applications: Bone density and osteoporosis treatment, hypogonadism (primary and secondary), libido improvement, cognitive and mood enhancements.
  • End Users: Ambulatory surgical centers, clinics, and hospitals.
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina); Europe, Middle East & Africa (including key markets such as United Kingdom, Germany, France, Saudi Arabia, and South Africa); Asia-Pacific (including China, India, Japan, Australia, South Korea, and Southeast Asian countries).
  • Industry Coverage: Over 30 key companies including pharmaceutical giants, specialty firms, and emerging innovators operating globally.

Primary Keyword: Testosterone Replacement Therapy

Key Takeaways for Senior Leaders

  • Personalized medicine is moving the market beyond standard dosing, with patient-specific regimens receiving growing clinical support across treatment settings.
  • Digital adherence tools and remote monitoring platforms are enhancing patient engagement while supporting outcomes-based approaches favored by payers.
  • Product innovation is increasing, particularly across non-injectable and minimally invasive delivery solutions, giving rise to new demand segments.
  • Market players are expanding portfolios by integrating therapies that address comorbidities such as osteoporosis and metabolic dysfunction, reflecting a more holistic care model.
  • Strategic partnerships—spanning digital health, specialist clinics, and local manufacturing—are enabling access expansion, platform integration, and improved supply chain agility.

Tariff Impact on U.S. TRT Market

New United States tariffs on imported active pharmaceutical ingredients and device components have forced manufacturers to reassess procurement and production strategies. Many organizations are increasing domestic manufacturing or diversifying sourcing to manage cost volatility. The cost pressures have led to varied pricing responses, increased localized supply, and driven further competition between branded and generic therapies. These changes are triggering supply chain innovation while altering the pricing and distribution landscape within the U.S. market.

Methodology & Data Sources

This report applies rigorous research processes, combining primary interviews with endocrinologists and payers with in-depth secondary analysis of regulatory filings, clinical trials, and published literature. Proprietary data aggregation and triangulation techniques support reliable market share validation and competitor assessment. All data has been cross-validated and ethically sourced to ensure robust actionable insights for decision-making.

Why This Report Matters

  • Enables leadership teams to benchmark operational strategies against the latest segmentation and technology adoption trends in testosterone replacement therapy.
  • Empowers stakeholders to identify high-impact opportunities and prepare for evolving regulatory and competitive pressures.
  • Supports informed investment and alliance decisions across a dynamic, regionally variant, and innovation-driven landscape.

Conclusion

These insights empower industry leaders to navigate the complex TRT market using evidence-based strategies. Companies that align innovation, operational excellence, and patient-focused care are positioned to drive sustainable growth and resilient market leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Testosterone Replacement Therapy Market, by Treatment Method
8.1. Introduction
8.2. Implants/Pellets
8.3. Injectable
8.3.1. Intramuscular
8.3.2. Subcutaneous
8.4. Intranasal Medications
8.5. Oral Medications
8.6. Patches
8.6.1. Cheek/Buccal
8.6.2. Transdermal
8.7. Topical Gel
9. Testosterone Replacement Therapy Market, by Application
9.1. Introduction
9.2. Bone Density & Osteoporosis Treatment
9.3. Hypogonadism
9.3.1. Primary Hypogonadism
9.3.2. Secondary Hypogonadism
9.4. Libido Improvement
9.5. Mood & Cognitive Improvements
10. Testosterone Replacement Therapy Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Clinics
10.4. Hospitals
11. Americas Testosterone Replacement Therapy Market
11.1. Introduction
11.2. United States
11.3. Canada
11.4. Mexico
11.5. Brazil
11.6. Argentina
12. Europe, Middle East & Africa Testosterone Replacement Therapy Market
12.1. Introduction
12.2. United Kingdom
12.3. Germany
12.4. France
12.5. Russia
12.6. Italy
12.7. Spain
12.8. United Arab Emirates
12.9. Saudi Arabia
12.10. South Africa
12.11. Denmark
12.12. Netherlands
12.13. Qatar
12.14. Finland
12.15. Sweden
12.16. Nigeria
12.17. Egypt
12.18. Turkey
12.19. Israel
12.20. Norway
12.21. Poland
12.22. Switzerland
13. Asia-Pacific Testosterone Replacement Therapy Market
13.1. Introduction
13.2. China
13.3. India
13.4. Japan
13.5. Australia
13.6. South Korea
13.7. Indonesia
13.8. Thailand
13.9. Philippines
13.10. Malaysia
13.11. Singapore
13.12. Vietnam
13.13. Taiwan
14. Competitive Landscape
14.1. Market Share Analysis, 2024
14.2. FPNV Positioning Matrix, 2024
14.3. Competitive Analysis
14.3.1. Acerus Pharmaceuticals Corporation
14.3.2. Actiza Pharmaceutical Pvt. Ltd.
14.3.3. ADVANZ PHARMA Corp.
14.3.4. Alembic Limited
14.3.5. ASKA Pharmaceutical Co., Ltd.
14.3.6. Aurobindo Pharma Limited
14.3.7. Bausch Health Companies Inc.
14.3.8. Bayer AG
14.3.9. Besins Healthcare Monaco S.A.M.
14.3.10. Bora Pharmaceuticals Co., Ltd.
14.3.11. Cipla Limited
14.3.12. Dr. Reddy's Laboratories Limited
14.3.13. Eli Lilly and Company
14.3.14. Endo International PLC
14.3.15. EVER Pharma Jena GmbH
14.3.16. Grünenthal
14.3.17. Halozyme, Inc.
14.3.18. Hikma Pharmaceuticals PLC
14.3.19. LIPOCINE Inc.
14.3.20. Lupin Limited
14.3.21. Marius Pharmaceuticals, Inc.
14.3.22. Perrigo Company PLC
14.3.23. Pfizer Inc.
14.3.24. REGENX Health
14.3.25. Simple Pharma
14.3.26. TesoRx Pharma, LLC
14.3.27. Teva Pharmaceutical Industries Ltd.
14.3.28. Tolmar, Inc.
14.3.29. Xiromed LLC
14.3.30. Zydus Lifesciences Limited
15. ResearchAI
16. ResearchStatistics
17. ResearchContacts
18. ResearchArticles
19. Appendix
List of Figures
FIGURE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET MULTI-CURRENCY
FIGURE 2. TESTOSTERONE REPLACEMENT THERAPY MARKET MULTI-LANGUAGE
FIGURE 3. TESTOSTERONE REPLACEMENT THERAPY MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2030 (%)
FIGURE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. TESTOSTERONE REPLACEMENT THERAPY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY IMPLANTS/PELLETS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INTRANASAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY ORAL MEDICATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY CHEEK/BUCCAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TOPICAL GEL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY BONE DENSITY & OSTEOPOROSIS TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PRIMARY HYPOGONADISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY SECONDARY HYPOGONADISM, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY LIBIDO IMPROVEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY MOOD & COGNITIVE IMPROVEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 35. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 36. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. UNITED STATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 45. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 46. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 47. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 48. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 49. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 50. CANADA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 52. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 53. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 54. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 56. MEXICO TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 58. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 59. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 60. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 61. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 62. BRAZIL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 64. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 65. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 66. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 67. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 68. ARGENTINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 72. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 73. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 74. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 76. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 77. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 78. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 79. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 80. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 81. UNITED KINGDOM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 82. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 83. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 84. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 85. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 87. GERMANY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 89. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 90. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 91. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 93. FRANCE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 95. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 96. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 97. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 99. RUSSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 101. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 102. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 103. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 105. ITALY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 107. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 108. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 109. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 111. SPAIN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 113. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 114. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 115. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 117. UNITED ARAB EMIRATES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 119. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 120. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 121. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 125. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 131. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 133. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 135. DENMARK TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 137. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 138. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 139. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 141. NETHERLANDS TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 143. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 144. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 145. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 147. QATAR TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 149. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 150. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 151. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 153. FINLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 154. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 155. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 156. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 157. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 159. SWEDEN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 160. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 161. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 162. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 163. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 164. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 165. NIGERIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 166. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 167. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 168. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 169. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 171. EGYPT TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 172. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 173. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 174. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 175. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 176. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 177. TURKEY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 178. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 179. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 180. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 181. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 182. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 183. ISRAEL TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 184. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 185. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 186. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 187. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 188. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 189. NORWAY TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 190. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 191. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 192. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 193. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 194. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 195. POLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 196. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 197. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 198. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 199. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 201. SWITZERLAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 202. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 203. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 204. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 205. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 206. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 207. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. ASIA-PACIFIC TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 209. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 210. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 211. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 212. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 214. CHINA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 215. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 216. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 217. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 218. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 220. INDIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 221. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 222. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 223. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 224. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 226. JAPAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 227. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 228. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 229. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 230. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 232. AUSTRALIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 234. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 235. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 236. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 238. SOUTH KOREA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 239. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 240. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 241. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 242. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 244. INDONESIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 245. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 246. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 247. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 248. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 250. THAILAND TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 251. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 252. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 253. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 254. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 256. PHILIPPINES TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 258. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 259. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 260. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 262. MALAYSIA TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 263. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 264. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 265. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 266. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 268. SINGAPORE TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 269. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 270. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 271. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 272. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 274. VIETNAM TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 275. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY TREATMENT METHOD, 2018-2030 (USD MILLION)
TABLE 276. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY INJECTABLE, 2018-2030 (USD MILLION)
TABLE 277. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY PATCHES, 2018-2030 (USD MILLION)
TABLE 278. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY HYPOGONADISM, 2018-2030 (USD MILLION)
TABLE 280. TAIWAN TESTOSTERONE REPLACEMENT THERAPY MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 281. TESTOSTERONE REPLACEMENT THERAPY MARKET SHARE, BY KEY PLAYER, 2024
TABLE 282. TESTOSTERONE REPLACEMENT THERAPY MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Testosterone Replacement Therapy market report include:
  • Acerus Pharmaceuticals Corporation
  • Actiza Pharmaceutical Pvt. Ltd.
  • ADVANZ PHARMA Corp.
  • Alembic Limited
  • ASKA Pharmaceutical Co., Ltd.
  • Aurobindo Pharma Limited
  • Bausch Health Companies Inc.
  • Bayer AG
  • Besins Healthcare Monaco S.A.M.
  • Bora Pharmaceuticals Co., Ltd.
  • Cipla Limited
  • Dr. Reddy's Laboratories Limited
  • Eli Lilly and Company
  • Endo International PLC
  • EVER Pharma Jena GmbH
  • Grünenthal
  • Halozyme, Inc.
  • Hikma Pharmaceuticals PLC
  • LIPOCINE Inc.
  • Lupin Limited
  • Marius Pharmaceuticals, Inc.
  • Perrigo Company PLC
  • Pfizer Inc.
  • REGENX Health
  • Simple Pharma
  • TesoRx Pharma, LLC
  • Teva Pharmaceutical Industries Ltd.
  • Tolmar, Inc.
  • Xiromed LLC
  • Zydus Lifesciences Limited

Table Information